BioCentury
ARTICLE | Company News

ImmuneRegen, NeoStem deal

May 3, 2010 7:00 AM UTC

NeoStem will evaluate the effect of ImmuneRegen's Homspera on stem cell differentiation when combined with NeoStem's very small embryonic-like (VSEL) stem cell technology. Homspera is a preclinical a...